• Product NameAtazanavir
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityAtazanavir(BMS-232632) is an highly potent HIV-1 protease inhibitor.
• Target NameHIV Protease inhibitor
• CAS No. 198904-31-3
• Calculated MW 704.87
• Formulation C38H52N6O7
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC
  Pathways:Microbiology&virology; Proteases/Proteasome
  Receptor:HIV Protease
  Boling pt:
  Melting pt:207-209C
  Solubility:DMSO: > 10 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Robinson BS, et al. Antimicrob Agents ChemOthers, 2000, 44(8), 2093-2099.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting